Hodges Capital Management Inc. Organon & Co. Transaction History

Hodges Capital Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $362,319 - $542,633	-16,915 Reduced 23.67%	54,553 $1.67 Million
Q4 2022 Feb 03, 2023	BUY	$23.31 - $28.61 $137,016 - $168,169	5,878 Added 8.96%	71,468 $2 Million
Q3 2022 Oct 21, 2022	SELL	$23.4 - $34.25 $1.89 Million - $2.76 Million	-80,722 Reduced 55.17%	65,590 $1.54 Million
Q2 2022 Jul 28, 2022	BUY	$31.66 - $38.9 $4.43 Million - $5.44 Million	139,802 Added 2147.5%	146,312 $4.94 Million
Q1 2022 May 12, 2022	SELL	$30.45 - $39.36 $6,699 - $8,659	-220 Reduced 3.27%	6,510 $227,000
Q4 2021 Feb 07, 2022	SELL	$28.67 - $37.13 $22,075 - $28,590	-770 Reduced 10.27%	6,730 $205,000
Q3 2021 Oct 06, 2021	BUY	$28.63 - $35.64 $214,725 - $267,300	7,500 New	7,500 $246,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hodges Capital Management Inc. with notifications on news.